Table 2.
Optimal Progress | ASD | Total Sample | t or X2, p | Effect Size | |
---|---|---|---|---|---|
| |||||
N = 19 | N = 171 | N = 190 | |||
Age in Months (M, SD) | |||||
| |||||
Average age at Time 1 | 26.21 (4.81) | 26.32 (4.37) | 26.31 (4.40) | t(187) = 0.10, p = .921 | d = .02 |
Average age at Time 2 | 51.47 (4.81) | 52.30 (9.75) | 52.22 (9.52) | t(188) = .36, p = .718, | d = .11 |
| |||||
Gender (N, %) | X2(1) = 2.69, p = .101 | ϕ = .12 | |||
| |||||
Male | 13 (68.4) | 143 (83.6) | 156 (82.1) | ||
Female | 6 (31.6) | 28 (16.4) | 34 (17.9) | ||
| |||||
Race/Ethnicity (N, %) | Fisher’s Exact Test = 3.85, p =.605 | ||||
| |||||
White | 16 (84.2) | 139 (81.3) | 155 (81.6) | ||
Hispanic/Latino | 1 (5.3) | 11 (6.4) | 12 (6.3) | ||
Black or African American | 0 (0) | 7 (4.1) | 7 (3.7) | ||
Asian or Pacific Islander | 1 (5.3) | 4 (2.3) | 5 (2.6) | ||
Biracial | 1 (5.3) | 3 (1.8) | 4 (2.1) | ||
Other | 0 (0) | 1 (0.6) | 1 (0.5) | ||
Not Available | 0 (0) | 6 (3.5) | 6 (3.2) |